259 related articles for article (PubMed ID: 30453529)
1. Intersection of Brain Development and Paediatric Diffuse Midline Gliomas: Potential Role of Microenvironment in Tumour Growth.
Loveson KF; Fillmore HL
Brain Sci; 2018 Nov; 8(11):. PubMed ID: 30453529
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.
Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA
Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876
[TBL] [Abstract][Full Text] [Related]
4. Current immunotherapeutic approaches to diffuse intrinsic pontine glioma.
Lin C; Smith C; Rutka J
Front Genet; 2024; 15():1349612. PubMed ID: 38774284
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C
Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282
[TBL] [Abstract][Full Text] [Related]
6. Diffuse Intrinsic Pontine Glioma : Clinical Features, Molecular Genetics, and Novel Targeted Therapeutics.
Mathew RK; Rutka JT
J Korean Neurosurg Soc; 2018 May; 61(3):343-351. PubMed ID: 29742880
[TBL] [Abstract][Full Text] [Related]
7.
Kluiver TA; Alieva M; van Vuurden DG; Wehrens EJ; Rios AC
Front Oncol; 2020; 10():92. PubMed ID: 32117746
[TBL] [Abstract][Full Text] [Related]
8. Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG).
Gwak HS; Park HJ
Crit Rev Oncol Hematol; 2017 Dec; 120():111-119. PubMed ID: 29198324
[TBL] [Abstract][Full Text] [Related]
9. Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas.
Welby JP; Kaptzan T; Wohl A; Peterson TE; Raghunathan A; Brown DA; Gupta SK; Zhang L; Daniels DJ
Front Oncol; 2019; 9():92. PubMed ID: 30873381
[TBL] [Abstract][Full Text] [Related]
10. An affinity for brainstem microglia in pediatric high-grade gliomas of brainstem origin.
Zats LP; Ahmad L; Casden N; Lee MJ; Belzer V; Adato O; Bar Cohen S; Ko SB; Filbin MG; Unger R; Lauffenburger DA; Segal RA; Behar O
Neurooncol Adv; 2022; 4(1):vdac117. PubMed ID: 35990702
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape.
Panditharatna E; Yaeger K; Kilburn LB; Packer RJ; Nazarian J
Cancer Genet; 2015; 208(7-8):367-73. PubMed ID: 26206682
[TBL] [Abstract][Full Text] [Related]
12. Genomic Insights into Diffuse Intrinsic Pontine Glioma.
Lapin DH; Tsoli M; Ziegler DS
Front Oncol; 2017; 7():57. PubMed ID: 28401062
[TBL] [Abstract][Full Text] [Related]
13. Treatment options for paediatric brainstem gliomas.
Khan DA; Laghari AA; Bari ME; Shamim MS
J Pak Med Assoc; 2019 Sep; 69(9):1400-1402. PubMed ID: 31511736
[TBL] [Abstract][Full Text] [Related]
14. Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma.
Tsoli M; Liu J; Franshaw L; Shen H; Cheng C; Jung M; Joshi S; Ehteda A; Khan A; Montero-Carcabosso A; Dilda PJ; Hogg P; Ziegler DS
Oncotarget; 2018 Jan; 9(7):7541-7556. PubMed ID: 29484131
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma.
Sasaki T; Watanabe J; He X; Katagi H; Suri A; Ishi Y; Abe K; Natsumeda M; Frey WH; Zhang P; Hashizume R
J Neurosurg; 2023 Jun; 138(6):1570-1579. PubMed ID: 36599085
[TBL] [Abstract][Full Text] [Related]
16. Pre-Clinical Models of Diffuse Intrinsic Pontine Glioma.
Misuraca KL; Cordero FJ; Becher OJ
Front Oncol; 2015; 5():172. PubMed ID: 26258075
[TBL] [Abstract][Full Text] [Related]
17. Diffuse intrinsic pontine glioma: poised for progress.
Warren KE
Front Oncol; 2012; 2():205. PubMed ID: 23293772
[TBL] [Abstract][Full Text] [Related]
18. The neurovascular unit in diffuse intrinsic pontine gliomas.
El-Khouly FE; Haumann R; Breur M; Veldhuijzen van Zanten SEM; Kaspers GJL; Hendrikse NH; Hulleman E; van Vuurden DG; Bugiani M
Free Neuropathol; 2021 Jan; 2():. PubMed ID: 37284626
[No Abstract] [Full Text] [Related]
19. Differential Expression of Wilms' Tumor Protein in Diffuse Intrinsic Pontine Glioma.
Lee S; Kambhampati M; Yadavilli S; Gordish-Dressman H; Santi M; Cruz CR; Packer RJ; Almira-Suarez MI; Hwang EI; Nazarian J
J Neuropathol Exp Neurol; 2019 May; 78(5):380-388. PubMed ID: 30990879
[TBL] [Abstract][Full Text] [Related]
20. Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma.
Amani V; Prince EW; Alimova I; Balakrishnan I; Birks D; Donson AM; Harris P; Levy JM; Handler M; Foreman NK; Venkataraman S; Vibhakar R
BMC Cancer; 2016 Aug; 16():647. PubMed ID: 27538997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
